Worth reading
69In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
8463000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 39th Stock Acquisition Rights (with provisions for adjustment of the exercise price) issued through a third-party allotment
発行・処分する株式数
Number of shares delivered during the month: 8,463,000 shares (all newly issued shares; 0 treasury shares transferred)
Intended allottee
EVO FUND (the allottee at the time of issuance; no new allotment is stated in the report on exercise status for the month)
Existing Shares and Increase
+10.00%Rate of increase
101,563,408 shares110,026,408Shares
10.0% (the exercise ratio subject to exercise restrictions; not the dilution ratio relative to the total number of issued shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price during the month under review was ¥21.0 or ¥22.0, and was ¥27.0 on 31 August. Details of the adjustment provisions and the lower limit: not disclosed
Number of Stock Acquisition Rights
Total issued: 600,000; exercised during the month under review: 84,630; unexercised at the end of the preceding month: 430,750; unexercised at the end of the month under review: 346,120
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
[{"date":"1 June 2026","type":"Issuance of the 39th Stock Acquisition Rights (with provisions for adjustment of the exercise price), with EVO FUND as the allottee","amount":"not disclosed"}]
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 39th Stock Acquisition Rights (with provisions for adjustment of the exercise price) issued through a third-party allotment |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 8,463,000 shares (all newly issued shares; 0 treasury shares transferred) |
| Intended allottee | EVO FUND (the allottee at the time of issuance; no new allotment is stated in the report on exercise status for the month) |
| Dilution Rate | 10.0% (the exercise ratio subject to exercise restrictions; not the dilution ratio relative to the total number of issued shares) |
| Total number of issued shares | 101,563,408 shares (as of the end of the month preceding the month under review, including 101 treasury shares) → 110,026,408 shares (the number as of the end of the preceding month plus the number of shares delivered during the month under review) |
| Exercise price | The exercise price during the month under review was ¥21.0 or ¥22.0, and was ¥27.0 on 31 August. Details of the adjustment provisions and the lower limit: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 600,000; exercised during the month under review: 84,630; unexercised at the end of the preceding month: 430,750; unexercised at the end of the month under review: 346,120 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | [{"date":"1 June 2026","type":"Issuance of the 39th Stock Acquisition Rights (with provisions for adjustment of the exercise price), with EVO FUND as the allottee","amount":"not disclosed"}] |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.